skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

14 studies were found about GSK1265744

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01641809

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00920426

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00812318

A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

Condition: HIV Infection

NCT ID: NCT00659191

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02076178

An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects

Condition: HIV-associated Lipodystrophy Syndrome

NCT ID: NCT01848340

A Study to Assess The Relative Bioavailability of New Tablet Formulations of GSK1265744 in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02059031

Study to Evaluate the Effect of GSK1265744 on Cardiac Conduction

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT02027454

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01593046

A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01754116

Relative Bioavailability Study of GSK1265744 Formulations

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01648257

A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Condition: Infections, Human Immunodeficiency Virus and Hepatitis

NCT ID: NCT01467531

DDI Study of Etravirine and GSK1265744

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00920296

A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01756131